Document is current
Any future updates will be listed below
-
Authors
Burrer, Achim http://orcid.org/0000-0003-2012-5655
Egger, Stephan T.
Spiller, Tobias R.
Kirschner, Matthias
Homan, Philipp
Seifritz, Erich
Vetter, Stefan
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 28 May 2024
First Online: 10 June 2024
Declarations
:
: Ethics approval and consent to participate.The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Canton of Zurich (BASEC-Nr. Req-2021–00376, approval date: 8 March 2021 and 26 October 2021).
: Not applicable.
: AB has received speaking and travel fees from Recordati, Schwabe, and Lundbeck. PH has received grants and honoraria from Novartis, Lundbeck, Mepha, Janssen, Boehringer Ingelheim, and Neurolite outside of this work. ES has received in the last 3 years honoraria and grants for advice and educational lectures from Lundbeck Switzerland, Schwabe Switzerland and Germany, Janssen Switzerland, Otsuka Pharmaceutical Switzerland, Mepha Pharma Switzerland, Recordati Switzerland, Sunovion Pharma UK, and Angelini. The other authors declare that they have no competing interests in this section.
